EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Triphasic Adrenocorticotropic Hormone Dynamics During Immune Checkpoint Inhibitor Therapy in a Patient With Malignant Melanoma

Natsumi Kuwata, Natsuko Ohashi, Maya Yonishi-Nakamura, Takashi Suzue, Kimihiro Nishimura, Koichiro Murata, Shogo Ida, Itsuko Miyazawa, Akira Shimatsu, Yutaka Takahashi, Shinji Kume

AACE Endocrinology and Diabetes · 2026-07 · 13 (4) · 638-642

DOI: 10.1016/j.aed.2026.03.014 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-07. Verfasst von Natsumi Kuwata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adrenocorticotropic hormonehypophysitisimmune checkpoint inhibitorsecondary adrenal insufficiency

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
  • Department of Diabetes and Endocrinology, Kyoto Okamoto Memorial Hospital, Kyoto, Japan.
  • Advanced Medical Care Center, Omi Medical Center, Kusatsu, Shiga, Japan.
  • Department of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara, Japan.

Zitieren

APA

Kuwata, N., Ohashi, N., Yonishi-Nakamura, M., Suzue, T., Nishimura, K., Murata, K., Ida, S., Miyazawa, I., Shimatsu, A., Takahashi, Y., & Kume, S. (2026). Triphasic Adrenocorticotropic Hormone Dynamics During Immune Checkpoint Inhibitor Therapy in a Patient With Malignant Melanoma. AACE Endocrinology and Diabetes, 13(4), 638-642. https://doi.org/10.1016/j.aed.2026.03.014

Vancouver

Kuwata N, Ohashi N, Yonishi-Nakamura M, Suzue T, Nishimura K, Murata K, et al. Triphasic Adrenocorticotropic Hormone Dynamics During Immune Checkpoint Inhibitor Therapy in a Patient With Malignant Melanoma. AACE Endocrinology and Diabetes. 2026;13(4):638-642. doi:10.1016/j.aed.2026.03.014

BibTeX
@article{Kuwata2026,
  author = {Kuwata, Natsumi and Ohashi, Natsuko and Yonishi-Nakamura, Maya and Suzue, Takashi and Nishimura, Kimihiro and Murata, Koichiro and Ida, Shogo and Miyazawa, Itsuko and Shimatsu, Akira and Takahashi, Yutaka and Kume, Shinji},
  title = {Triphasic Adrenocorticotropic Hormone Dynamics During Immune Checkpoint Inhibitor Therapy in a Patient With Malignant Melanoma},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {638--642},
  doi = {10.1016/j.aed.2026.03.014}
}
Kostenlos starten →